摘要：In my work as a statistician in the Non-Clinical Statistics and Biostatistical Applications group within Pfizer Global Research and Development I have the opportunity to perform statistical analysis in a wide variety of domains. One of these domains is pharmacogenomics, in which we attempt to determine the relationship between the genetic variability of individual patients and disease status, disease progression, treatment efficacy, or treatment side effect profile.
